86 related articles for article (PubMed ID: 3038613)
1. Angiotensin I-converting enzyme in isolated human glomeruli.
Chansel D; Morin JP; Borghi H; Ardaillou N; Ardaillou R
FEBS Lett; 1987 Aug; 220(1):247-52. PubMed ID: 3038613
[TBL] [Abstract][Full Text] [Related]
2. High affinity binding of ramiprilat on isolated human glomeruli.
Albus U; Kress I; Linz W; Vasmant D; Delarue F; Sraer JD
Biochem Pharmacol; 1988 Dec; 37(24):4679-84. PubMed ID: 2849453
[TBL] [Abstract][Full Text] [Related]
3. Acute but not chronic angiotensin-converting enzyme inhibition induces enzyme synthesis in the glomerulus of the spontaneously hypertensive rat.
Hodge G; Makarious MM; Charlesworth JA; Duggan KA
Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):460-2. PubMed ID: 9171960
[TBL] [Abstract][Full Text] [Related]
4. Perindopril, a new angiotensin converting enzyme inhibitor--clinical pharmacological studies in healthy subjects.
Reid JL; Lees KR; Perret L
Clin Exp Hypertens A; 1987; 9(2-3):361-4. PubMed ID: 3038395
[TBL] [Abstract][Full Text] [Related]
5. Renoprotective differences between perindopril and enalapril in the diabetic hypertensive rat do not reflect glomerular angiotensin-converting enzyme activity.
Duggan KA; Hodge G; Makarious MM; Charlesworth JA
Clin Sci (Lond); 1998 May; 94(5):511-6. PubMed ID: 9682674
[TBL] [Abstract][Full Text] [Related]
6. High affinity binding sites for Perindopril a new inhibitor of angiotensin-I-converting enzyme (ACE) in the rabbit kidney: possible evidence for localization of ACE in endothelial structures and in glomerular mesangium.
Morin JP; Moulin B; Borghi H; Fillastre JP
Int J Tissue React; 1989; 11(2):81-92. PubMed ID: 2559047
[TBL] [Abstract][Full Text] [Related]
7. Measurement of angiotensin converting enzyme inhibitors in serum by radioinhibitor binding displacement assay.
Jackson B; Cubela R; Johnston CI
Biochem Pharmacol; 1987 Apr; 36(8):1357-60. PubMed ID: 3036166
[TBL] [Abstract][Full Text] [Related]
8. High-affinity binding of the converting enzyme inhibitor, ramiprilat, to isolated human glomeruli.
Becker RH; Albus U; Kress I; Linz W; Vasmant D; Delarue F; Sraer JD
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S31-4. PubMed ID: 2474098
[TBL] [Abstract][Full Text] [Related]
9. Characterization of angiotensin converting enzyme by [3H]captopril binding.
Strittmatter SM; Snyder SH
Mol Pharmacol; 1986 Feb; 29(2):142-8. PubMed ID: 3005826
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tissue angiotensin converting enzyme by perindopril: in vivo assessment in the rat using radioinhibitor binding displacement.
Jackson B; Cubela RB; Johnston CI
J Pharmacol Exp Ther; 1988 Jun; 245(3):950-5. PubMed ID: 2838609
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme binding sites in human heart and lung: comparison with rat tissues.
Vago T; Bevilacqua M; Conci F; Baldi G; Ongini E; Chebat E; Monopoli A; Norbiato G
Br J Pharmacol; 1992 Nov; 107(3):821-5. PubMed ID: 1335341
[TBL] [Abstract][Full Text] [Related]
12. Effects of perindopril on angiotensin converting enzyme in tissues of the rat.
Jackson B; Cubela RB; Johnston CI
J Hypertens Suppl; 1988 Dec; 6(3):S51-4. PubMed ID: 2852236
[TBL] [Abstract][Full Text] [Related]
13. Characterization of angiotensin converting enzyme (ACE) in the testis and assessment of the in vivo effects of the ACE inhibitor perindopril.
Jackson B; Cubela RB; Sakaguchi K; Johnston CI
Endocrinology; 1988 Jul; 123(1):50-5. PubMed ID: 2838262
[TBL] [Abstract][Full Text] [Related]
14. Acute and chronic effects of perindopril on tissue angiotensin converting enzyme activity.
Mendelsohn FA; Pupic V; Jackson B; Cubela R; Johnston CI
Am J Hypertens; 1991 Mar; 4(3 Pt 2):220S-225S. PubMed ID: 1645981
[TBL] [Abstract][Full Text] [Related]
15. Effect of angiotensin-converting enzyme two-week inhibition on renal angiotensin II receptors and renal vascular reactivity in SHR.
Haddad G; Garcia R
J Mol Cell Cardiol; 1997 Feb; 29(2):813-22. PubMed ID: 9140837
[TBL] [Abstract][Full Text] [Related]
16. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.
Michaud A; Williams TA; Chauvet MT; Corvol P
Mol Pharmacol; 1997 Jun; 51(6):1070-6. PubMed ID: 9187274
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of [3H]captopril binding by peptide analog angiotensin converting enzyme inhibitors.
Toll L; Almquist RG
Biochem Biophys Res Commun; 1986 Mar; 135(3):770-7. PubMed ID: 3008745
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibition and autoregulation of glomerular filtration.
Plante GE; Chainey A; Sirois P; Devissaguet M
J Hypertens Suppl; 1988 Dec; 6(3):S69-73. PubMed ID: 3066878
[TBL] [Abstract][Full Text] [Related]
19. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
MacFadyen RJ; Lees KR; Reid JL
Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
[TBL] [Abstract][Full Text] [Related]
20. Differential angiotensin-converting enzyme inhibition in brain after oral administration of perindopril demonstrated by quantitative in vitro autoradiography.
Sakaguchi K; Chai SY; Jackson B; Johnston CI; Mendelsohn FA
Neuroendocrinology; 1988 Sep; 48(3):223-8. PubMed ID: 2847068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
